Incomplete Kawasaki Disease in a Three Month Old Infant by M, Ashraf et al.
Ashraf et al                                                     Incomplete Kawasaki Disease 
Vol 1 / Issue 1 / Jan-Mar 2015                                                            Indian J Case Reports / 11 
Case Report  
Incomplete Kawasaki Disease in a Three Month Old Infant 
Ashraf M, Taleb A, Shamsah A, Al-Sharhan H 
From, Department of Pediatrics, Pediatric Emergency Unit, Mubarak Al-Kabeer Hospital, Kuwait 
Correspondence to: Dr Hind Al-Sharhan, Department of Pediatrics, Pediatric Emergency Unit, Mubarak Al-Kabeer Hospital, 
Kuwait. Email - hd.alsharhan@live.com 
Received: 04 December 2014   Initial Review: 20 December 2014   Accepted: 31 December 2014 Published Online: 09 January 2015 
ABSTRACT 
Kawasaki disease (KD) is an acute systemic vasculitis of unknown aetiology that has largely replaced rheumatic heart disease 
as a cause of acquired heart disease in children of many developed countries. We report a case of incomplete KD in a three-
month-old girl. The diagnosis of incomplete KD was made after exclusion of conditions with similar presentation. She was 
treated with intravenous immunoglobulin following which she made an uneventful recovery but demonstrated thrombocytosis 
in the second week of convalescence. It is important for the treating physicians to become aware of the incomplete KD as 
prompt diagnosis and early treatment of these patients with intravenous immunoglobulin is vital for the prevention of lethal 
coronary complications. Physicians need to have a "high index of suspicion" for KD and even, higher for IKD. 
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awasaki disease (KD) is an acute vasculitis of 
unknown etiology that has been found in all 
pediatric age groups. However, most cases occur 
in children aged 6 months to 8 years old. After Henoch-
Schonlein purpura, KD is the commonest vasculitic 
disorder of children [1-6]. It is a disease of variable 
incidence. In Japan, the incidence is 80-100 per 100,000 
children under five years of age, 8 in the USA, 3-6 in 
Europe [1-3]. Despite such high incidence worldwide, the 
number of reported cases from Kuwait remains meager 
and is largely confined to typical KD. It is likely that many 
cases of KD and more of incomplete KD (IKD) go 
unnoticed, especially in the absence of a precise diagnostic 
test. 
The diagnosis is confirmed by the presence of fever 
lasting for at least 5 days and four of the following criteria, 
without evidence of another known disease: a) bilateral 
non-purulent conjuctival injection; b) changes of mucous 
membranes in the upper respiratory tract such as injected 
pharynx and lips, strawberry tongue;  c) polymorphous 
rash; d) changes in the extremities such as peripheral 
edema, erythema or periungual desquamation; and e) 
acute, usually unilateral, non-purulent cervical adenopathy. 
Since there is no single diagnostic laboratory test, 
physicians use laboratory markers of inflammation (high 
white blood cell count, C-reactive protein, and erythrocyte 
sedimentation rate) to establish the diagnosis of Kawasaki 
disease. In some cases not all the criteria are met, and the 
coronary artery abnormalities develop later as a 
complication. The term incomplete (or atypical) Kawasaki 
is used for such patients [7-9]. Coronary artery aneurysms 
develop in 20–25% of untreated patients but 
administration of intravenous immunoglobulin within the 
first 10 days of fever significantly reduces this incidence 
[9]. We report a case of a three month old infant with IKD 
who presented with fever followed by red lips, strawberry 
tongue and non purulent conjunctivitis. 
CASE REPORT 
A three months old girl presented with six days history of 
fever and lethargy. There was no history of vomiting or 
diarrhea. Her past medical history was uneventful. 
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Systemic review was noncontributory apart from mild 
eczema.  She was seen three times by different 
pediatricians who diagnosed her as having acute otitis 
media; she was given amoxicillin with clavulinic acid and 
cefpodoxime respectively, with no changes in her overall 
wellbeing despite treatment for five days.   
On physical examination, she looked unwell; her 
temperature: 39.6
o
c; oxygen saturation: 98% in room air; 
heart rate: 150 per minute; respiratory rate: 35 per minute; 
there was obvious non purulent conjunctivitis and mucus 
membrane changes in the form of red lips and strawberry 
tongue.  
The mother agreed that the above two features 
appeared within the preceding 48 hours. There were no 
skin rashes, no lymph node enlargement and no extremity 
changes. 
Although, she was three month old with only two 
features of Kawasaki disease, IKD was suspected and the 
following investigations were ordered. Her complete blood 
count (CBC) showed white blood cell count (WBC) of 
27,000/mm
3
; hemoglobin (Hb): 9.7 gm/dl, platelets: 
915,000/mm
3
; erythrocyte sedimentation rate (ESR): 97 
mm/hour; C reactive protein (CRP): 75 mg/dl; There was 
markedly elevated liver transaminases.  Urine analysis 
showed mild pyuria (30/ml). Blood and urine samples 
were also collected for culture and sensitivity which were 
sterile. 
The clinical features, the duration of fever, the 
unresponsiveness to antibiotics and the laboratory results, 
all indicated that the diagnosis of IKD was highly 
probable. Accordingly, she was immediately started on 
IVIG and high dose aspirin. Pediatric cardiologist was 
consulted and echocardiogram was done and it was 
unremarkable. She showed dramatic response to IVIG 
within 24 hours. Her fever subsided, her conjuctival and 
mucus membrane changes improved. She was kept under 
observation for another 24 hours during which she 
remained asymptomatic then she was discharged home on 
aspirin.  
A follow up CBC and Echocardiogram were arranged. 
Platelet count normalized within 4 weeks, her second 
Echocardiogram (after 6 weeks) and third Echocardiogram 
(after 3 months) showed coronary ectasia, consequently 
low dose aspirin was continued. 
DISCUSSION 
Kawasaki disease is a generalized vasculitis that affects 
medium-size arteries. Ninety percent of cases involve 
children younger than five years. The disease is relatively 
uncommon in children younger than six months. Boys are 
affected about 50% more often than the girls. The disease 
occurs year round, but cases tend to cluster in the winter 
and spring [10]. Patients may be found to have incomplete 
Kawasaki disease if they exhibit fever and some of the 
classic symptoms but not enough to meet the diagnostic 
criteria. Infants, especially those younger than six months, 
are especially likely to have an incomplete presentation. 
The finding most consistently absent in incomplete 
Kawasaki disease is cervical lymphadenopathy (present in 
only 10%). Rash is absent in 50%, and extremity changes 
are absent in 40%. Mucous membrane changes are the 
most consistent finding. 
Laboratory evaluation is recommended for the patients 
a) younger than six months with unexplained fever for ≥7 
days, even if they exhibit none of the classic symptoms of 
Kawasaki disease and b) of any age with unexplained 
fever for ≥5 days who exhibit three or fewer of the classic 
symptoms [11]. Laboratory evaluation should include 
complete blood cell count, ESR, CRP level, urinalysis, 
alanine aminotransferase level, and serum albumin level. 
The disease tends to be self-limiting and usually 
resolves without treatment within about 12 days [12]. 
However, serious cardiac complications can occur, such as 
coronary artery aneurysms, decreased myocardial 
contractility, congestive heart failure (CHF), arrhythmias, 
and myocardial ischemia. Early recognition and treatment 
significantly reduces the incidence of these complications. 
Without treatment, 20% to 25% of patients develop 
cardiac complications while with treatment, the incidence 
decreases to 4% [10-14]. Treatment should be initiated as 
soon as the diagnosis is made and should involve the 
administration of intravenous immunoglobulin (IVIG) and 
high-dose aspirin. 
The overall prognosis for patients with Kawasaki 
disease is dependent on the severity of coronary artery 
involvement as a risk factor for myocardial ischemia [15]. 
Patients without any cardiovascular abnormalities tend to 
do well and are generally asymptomatic at their long-term 
follow-up examination. 
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CONCLUSION  
It is important for the treating physicians to become aware 
of the incomplete KD as prompt diagnosis and early 
treatment of these patients with intravenous 
immunoglobulin is vital for the prevention of lethal 
coronary complications. Physicians need to have a "high 
index of suspicion" for KD and even, higher for IKD. 
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